NCT02207556
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- Froedtert & Medical College of Wisconsin Milwaukee, Wisconsin, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,606 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
Completed
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
NCT02933320
- Conditions
- B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- Leicester Royal Infirmary Leicester, England, United Kingdom
- Christie Hospital Manchester, England, United Kingdom
- Oxford Cancer and Haematology Centre, Churchill Hospital Oxford, England, United Kingdom
- Derriford Hospital Plymouth, United Kingdom
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Southern Cancer Center Mobile, Alabama, United States
- Sansum Clinic - USOR Santa Barbara, California, United States
- Colorado Blood Cancer Institute - PPDS Denver, Colorado, United States
- Rocky Mountain Cancer Centers (Williams) - USOR Denver, Colorado, United States
NCT04439240
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States
NCT01822509
- Conditions
- Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Bone Marrow Diseases, +44 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
NCT02703779
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- The University of Kansas Medical Center Westwood, Kansas, United States
NCT01592981
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom
- Royal United Hospital Bath, United Kingdom
- Birmingham Heartlands Hospital Birmingham, United Kingdom
- City Hospital Birmingham, United Kingdom
NCT02569320
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01768845
- Conditions
- Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Anemia, +42 more
- Locations
-
- West Virginia University Hospitals Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States
Completed
UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment
NCT02499081
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- University of Arkansas for Medical Science Little Rock, Arkansas, United States